Can mapping patient profiles unlock better breathing therapy for bronchiectasis?
NCT ID NCT07733323
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This study examines the medical records of 270 adults with bronchiectasis (a lung condition causing persistent cough and breathlessness) who were treated with respiratory physiotherapy. Researchers aim to identify common patterns in lung function, symptoms, and overall health to better understand which patients benefit most from rehabilitation. The goal is to improve how care is tailored to individual needs.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help tailor respiratory physiotherapy to individual patient needs, potentially improving outcomes for people with bronchiectasis.
- What could go wrong
- This is an observational study that looks back at existing medical records, so it cannot prove cause and effect. The findings may not apply to all patients with bronchiectasis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 270 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2026
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
This study analyses a cohort of 270 adult patients from the A Coruña and Cee health district who were diagnosed with bronchiectasis at the Pulmonology Department of A Coruña Hospital via computed tomography and treated at the Respiratory Physiotherapy Unit of the Rehabilitation Department at A Coruña Hospital.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria: * Patients diagnosed with BX via imaging studies such as high-resolution computed tomography, in accordance with validated clinical and radiological criteria. * Patients treated at the Respiratory Rehabilitation Unit of the Rehabilitation Service in the A Coruña and Cee area between 1 January 2022 and 1 March 2026, having completed the physiotherapy intervention programme. * Adult patients, aged ≥18 years at the time of diagnosis. * Minimum information available in the electronic health record, including: demographic data (age, sex); data on bronchial colonisation; data on lung function (spirometry); records of exacerbations and/or hospital admissions; and data on respiratory treatments received. Exclusion criteria: * Patients with an uncertain or unconfirmed diagnosis of BX. * Patients with a diagnosis of cystic fibrosis. * Incomplete medical records that prevent the collection of variables essential to the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bronchiectasis adult are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Marítimo de Oza, Hospital a Coruña, SERGAS
A Coruña, A, 15006, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an inhaled drug ease bronchiectasis? a trial seeks answers
- Breathing and qigong: a drug-free approach to easier breathing for damaged lungs?
- Could your own lung cells heal damaged airways? a new trial aims to find out
- New drug CTX-187 takes aim at stubborn bacterial infections
- Lung patients may soon do rehab from home via app
- New study aims to find best exercise test for lung disease patients